|Videos|March 10, 2023
Utilizing ctDNA Assays in Colorectal Cancer for Treatment and Monitoring of Patients with Solid Tumors
The panel reviews the different settings in colorectal cancer where ctDNA is being investigated as a tool for treatment and monitoring.
Advertisement
Episodes in this series
Advertisement
Related to this article
More than two-thirds of patients with mismatch repair–deficient locally advanced rectal cancer achieved a clinical complete response with dostarlimab alone.
Advertisement
Advertisement
Trending on CancerNetwork
1
Prior Regimen Did Not Affect Daraxonrasib Benefit in Pretreated Pancreatic Cancer
2
Petosemtamab/Pembrolizumab Improves OS in First-Line PD-L1–Positive HNSCC
3
What Are the Top Takeaways for Neuroendocrine Carcinoma From 2026 ESMO?
4
Sacituzumab Govitecan PFS Benefit Holds Across Subgroups in Untreated mTNBC
5